Saber Akhondi was born in Iran, September 1982. He obtained his MSc degree in Bioinformatics and Systems Biology from Chalmers University of Technology, Sweden, in 2011. He did his thesis at AstraZeneca in 2010 with the title of "Integrating heterogeneous ranked sources with different reliabilities: A case study of Gene-Disease associations".
In 2011 he started working as a Scientist and a Vocabulary developer at AstraZeneca R&D Molndal, Sweden, where he was mainly involved in two projects called iSIM and Pharmaconnect.
In December 2011 he started as a PhD student within the biosemantics group. His research is aimed at Exploring Chemical and Biological Named Entity Recognition (Chemical NER, BioNER) in drug discovery. The project is a collaboration between AstraZeneca and the department of Medical Informatics at Erasmus MC.